Drawing for ACCEL CLINICAL SERVICES

USPTO serial 77789409

ACCEL CLINICAL SERVICES

Reviewed by CopyMark Law Group

Reg. 3774386Status 800Registered
Filing date
Status date
Registration date
Apr 13, 2010
Examiner
PILARO, MARK F
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with ACCEL CLINICAL SERVICES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark A. Wright

Mark A. Wright McLane Middleton, P.A.900 Elm St., P.O. Box 326Manchester, NH 03105-0326United States

Goods and services

ClassDescriptionStatusFirst use
035BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL RESEARCH AND CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, PRE-STUDY DOCUMENT COLLECTION AND REVIEW, SITE SELECTION, VISITS AND AUDITS, SITE COMPLIANCE, PROJECT TRACKING AND MONITORING REPORTS, NEGOTIATION AND ADMINISTRATION OF INVESTIGATOR GRANTS AND CLINICAL TRIAL BUDGETS AND CONTRACTS, FINANCIAL AND MANAGEMENT ACCOUNTING, DISTRIBUTION, COORDINATION AND TRACKING OF CLINICAL TRIAL PRODUCTS AND MATERIALS, REGULATORY DOCUMENT PROCESSING, LABORATORY SELECTION AND COORDINATION; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING SITE AND STUDY-SPECIFIC SUBJECT RECRUITMENT STRATEGIES AND PROGRAMS IN THE NATURE OF CONTINGENCY STRATEGIES AND SOLUTIONS TO ADDRESS SPECIFIC PROJECT CHALLENGES; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING THE DEVELOPMENT OF ALL STUDY RELATED DOCUMENTS AND MATERIALS IN THE NATURE OF STUDY PROTOCOLS, CONTRACTS, BUDGETS, AMENDMENTS, PAPER AND ELECTRONIC CASE REPORT FORMS, INFORMED CONSENT FORMS, SAFETY NARRATIVES, PRESENTATION POSTERS, AND TRAINING MANUALS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PRE-CLINICAL THROUGH PHASE FOUR CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, MANAGING ALL ASPECTS OF STUDY, DRUG RECONCILIATION, AND INVENTORY AND DISTRIBUTION REPORTS, MANAGING ALL ASPECTS OF CLINICAL TRIALS, NAMELY, MANAGING INVESTIGATORS, COORDINATORS, MONITORS, TECHNICIANS, AND PARTICIPANTS, ETHICAL REVIEWS, INVESTIGATOR MEETINGS, DATABASES, STATISTICAL ANALYSES AND REPORTING, RANDOMIZATION LOGISTICS, RECRUITMENT OF INVESTIGATORS, COORDINATORS, MONITORS, TECHNICIANS AND PARTICIPANTS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, NAMELY, PHASE ONE THROUGH PHASE FOUR ADMINISTRATION OF CLINICAL TRIAL MANAGEMENT SERVICES, NAMELY, THE ADMINISTRATION OF PROTOCOLS INVOLVING VOLUNTEER RESEARCH PATIENTS AND THE RECRUITING OF SUCH VOLUNTEER RESEARCH PATIENTS; PROVIDING DATA MANAGEMENT SERVICES IN THE MEDICAL, PHARMACEUTICAL AND BIOTECHNOLOGICAL FIELDACTIVEAug 10, 2006
041PROVIDING TRAINING IN THE FIELD OF CLINICAL TRIALS AND CLINICAL TRIAL MANAGEMENT FOR THE PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIESACTIVEAug 10, 2006
042MEDICAL AND SCIENTIFIC RESEARCH CONSULTING REGARDING PRECLINICAL TO PHASE FOUR CLINICAL TRIALS; PROVIDING QUALITY ASSURANCE SERVICES IN THE PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIESACTIVEAug 10, 2006
045REGULATORY AFFAIRS, NAMELY, REVIEWING STANDARDS AND PRACTICES TO ASSURE COMPLIANCE WITH CLINICAL TRIAL LAWS AND REGULATIONSACTIVEAug 1, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 29, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 29, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 29, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 5, 2021NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jan 5, 2021RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 5, 202189AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 5, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 12, 2020E89RTEAS SECTION 8 & 9 RECEIVED—
Apr 13, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 7, 2016NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 7, 2016C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 7, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 28, 2016E815TEAS SECTION 8 & 15 RECEIVED—
Apr 13, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 26, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 26, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 5, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 5, 2009ALIEASSIGNED TO LIE—
Nov 18, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 18, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Nov 18, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 18, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 18, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 6, 2009FAXXFAX RECEIVED—
Nov 4, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2009DOCKASSIGNED TO EXAMINER—
Jul 28, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance